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Departments of Surgery, ~Guys and 2Newham Hospitals, and Department of Radiology, Guys Hospital, 
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Objective: To assess the success of percutaneous transluminal angioplasty (PTA) in treating infrainguinat graft-related 
stenoses. 
Design: Retrospective analysis of stenoses undergoing PTA over 6 years. 
Materials: Fifty-seven stenoses in 42 grafts. 
Methods: Site, length and type of stenoses recorded. Follow-up till discharge, graft occlusion or death. 
Results: PTA was successful in 48/57 stenoses in 36 grafts (G), with a poor result in seven. Further PTA was required 
in seven stenoses (7 G). One graft occluded at PTA and one stenosis was inaccessible. Overall graft (G) patency (median 
13 months) was 82% (1 year patency 84%). Of 48 successful PTAs (37 G), 36 remained patent (28 G), eight (4 G) 
occluded and four were lost to follow-up (4 G). Fourteen of thirty-six stenoses which remained patent required further 
intervention (seven PTA, six jump grafts, one vein patch). The four occlusions were associated with small veins (two), 
multiple stenoses (one) and a PTFE graft which occluded i0 days following PTA. Of the seven PTAs with a poor 
angiographic result, five remained patent, three after further intervention. 
Conclusion: PTA is the best treatment for localised stenoses. Stenoses >2 cm or multiple (three or more) stenoses are 
best treated surgically. Follow-up is essential, as 20% require further intervention. 
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Introduction 
Femoropopliteal and femorodistal bypass procedures 
are associated with failure rates of 20-75% at 5 years. ~ 
Thrombosis during the first postoperative month is 
due to errors of judgement or technique, or to a high 
peripheral resistance associated with poor run-off. 2
From 1 month to 2 years stenoses develop in 20-30% 
of vein grafts. 3'4 The reason for such stenoses is un- 
known. The pathology isintimal hyperplasia, but there 
is no relationship to sites of venous tributaries, valve 
cusps or clamp sites, s The presence of a macrophage 
or lymphocyte infiltrate and subendothelial smooth 
muscle cells in the pre-bypass vein may, however, be 
associated with subsequent graft stenoses. ~ When graft 
stenoses have been identified, surgical intervention 
has been reported to increase the secondary patency 
f rom 35-85%. 6A recent randomised prospective trial 
has shown that regular graft surveillance improves 
patency rates with vein but not prosthetic femoro- 
popliteal/crural grafts. 7
* Address correspondence to: Mr A. Houghton, Department of 
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The role of percutaneous transluminal ngioplasty 
(PTA) is not well defined. Some have suggested that 
PTA has an important role in the primary treatment 
of vein graft stenosesY while others consider that the 
long-term results of PTA are not good and recommend 
surgical treatment for such lesions. 6 It has been sug- 
gested that long stenoses (more than 2 cm) should 
be treated surgically, with the remainder undergoing 
PTA. 3 
Reported experience to date mainly deals with vein 
graft stenoses. There is almost no information on 
stenoses occurring in association with prosthetic grafts. 
The aim of this retrospective study was to assess 
the outcome of both vein and prosthetic graft-related 
stenoses ubmitted to PTA. 
Patients and Methods 
Information on all patients referred to a single ra- 
diology department with graft-related stenosis in- 
volving an infrainguinal graft was collated between 
September 1987 and June 1993. The patients were, 
with two exceptions, from two hospitals (Guys 22, 
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Newham General 18) and one radiologist (JR) was 
involved in all the angioplasties. During the latter part 
of this period a graft surveillance programme was in 
Operation, using continuous wave Doppler assessment 
(Quickscan - reference 9) of the whole graft and peri- 
anastomotic regions. All except six patients in the 
study were, however, picked up before the Quickscan 
became available, on the basis of symptoms and de- 
creased calf/brachial indices when seen in outpatients. 
The graft stenosis was then diagnosed at intra-arterial 
digital subtraction angiography (IADSA). 
Whenever possible, an ipsilateral antegrade f moral 
approach was used for angioplasty access. When this 
was not possible (e.g. proximal lesion, high graft ori- 
gin) a contralateral femoral approach, brachial ap- 
proach or occasionally direct graft puncture was used. 
In most instances a high pressure balloon (10-12 at- 
mospheres) was used with several inflations, as graft 
stenoses are generally more resistant to dilatation than 
native vessel stenoses. 
The site, length and type of stenoses arising in both 
vein and PTFE grafts were recorded. An anastomotic 
stenosis was defined as any stenosis of the graft or 
native vessel within 2 cm of graft insertion. The tech- 
nique and results of the angioplasties were assessed, 
and follow-up was until discharge from the clinic, 
irretrievable graft occlusion or known death of the 
patient. In the first part of the study period ankle/ 
brachial pressure indices were measured in the clinic. 
Subsequently, grafts were assessed by Quickscan at 
the time of outpatient clinic attendance. In both cases 
angiography was performed as indicated by patients' 
symptoms, ankte/brachial pressure indices or a sten- 
osis shown on Quickscan. A successful angioplasty 
result is defined as when full inflation of the balloon 
occurs without wasting and when the post-PTA study 
showed unequivocal improvement with less than 30% 
residual stenosis. 
Table 1. Graft-related angioplasty - technical results in 57 sten- 
oses .  
Successful 48 
Residual wasting/stenosis 7 
Occlusion 1 
Stenosis naccessible 1 
Table 2. Graft-related angioplasty - clinical outcome of48 "suc- 
cessful" angioplasties (36 grafts). 
Patent 36 
Occlusion 8 
Lost o follow-up 4 
No further intervention 27 
Further PTA* 6 
Jump grafts* 4 
Grafts 4 
* One patient had both PTA and jump graft. 
Table 3. Graft-related angioplasty - outcome of seven an- 
gioplasties with poor technical result (n = 7 grafts). 
Patent 
Further intervention 3
No intervention 2 
Occlusion 2 
Vein patch angioplasty 1 
Jump graft (6 months later) 1 
Further PTA (35 months later) 1 
(10 and 12 months later) 
the four graft body stenoses more than 2 years fol- 
lowing surgery were in PTFE grafts. 
Fifty-six angioplasty procedures were performed on 
the 43 grafts. The approaches were femoral antegrade 
(31), crossover femoral (14), brachial (six) and direct 
graft puncture (five). 
Follow-up data was obtained in 52/56 (93%) sten- 
oses (38 grafts) for a median time of 13 months (range 
0.5-48 months). Four patients (four stenoses) were lost 
to follow-up. The 1-year graft patency was 84% (27 
out of 32 grafts) and the overall graft patency at follow- 
up 82% (31 out of 38 grafts). Six grafts had occluded 
irretrievably (three V, three PTFE) and one patient 
had undergone an amputation for venous ulceration 
despite a functioning raft. 
Results 
Angioplasty was attempted for 57 stenoses in 43 infra- 
inguinal grafts (42 patients) between September 1987 
and June 1993, with 56 stenoses in 42 grafts being 
dilated. Of the 42 grafts, 34 were vein and eight PTFE. 
Twenty-one of the stenoses were in the body of the 
graft (B) and 35 in the anastomotic regions (A). Thirty- 
one of the stenoses (B 14, A 17) were associated with 
grafts performed in the preceding 12 months, nine 
stenoses (B three, A six) between 12 and 24 months 
previously, and 16 stenoses (B four, A 12) with grafts 
operated on more than 2 years previously. Two out of 
Technical results (Tables 1-3) 
A successful angioplasty was achieved in 48 stenoses. 
In seven, residual wasting of the balloon and/or sig- 
nificant residual stenosis was present on the post- 
angioplasty films. One PTFE graft occluded at PTA, 
requiring thrombectomy. 
Table 2 shows the outcome of "successful" PTAs 
(n =48). Thirty-six of the stenoses at follow-up were 
patent and associated with functioning rafts. Six of 
these had undergone further angioplasty procedures, 
and four had required jump grafts. Eight stenoses in 
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Table 4. Graft-related angioplasty- location and types of stenoses 
(n = 56 in 42 grafts). 
Graft body stenoses Anastomotic 
stenoses 








four grafts had occluded irretrievably (three vein, one 
PTFE). Of the three vein grafts, two were of generally 
poor calibre and one had four stenoses. 
Table 3 shows the outcome when the angioplasty 
result was considered technically poor (n = 7). At fol- 
low-up, five stenoses were associated with patent 
grafts (5 G). In two, this was achieved without further 
intervention. Surgical procedures had been required 
in two and one stenosis had undergone further PTA 
35 months later. The other two grafts had occluded: a
vein graft with four stenoses and one PTFE graft. 
Results related to types of graft stenosis (Table 4) 
There were 21 graft body (B) and 35 anastomotic (A) 
stenoses. Of the 21 graft body stenoses, 18 were in 
vein and three in PTFE grafts. 
Vein grafts. There were five long stenoses (Fig. 1) in 
five grafts. Although PTA was apparently successful 
in two, all five subsequently occluded or required 
surgery. 
Two vein grafts had web stenoses (Fig. 2) and nine 
(11 stenoses) short localised stenoses (Figs 3 and 4). 
These stenoses responded well to PTA, and nine out 
of 11 grafts were patent at median follow-up of 15 
months, with a second PTA being required in only 
two cases. The graft occlusions which did occur (two) 
were due to an associated unsuccessful PTA (one 
graft), and a poor calibre vein (one graft). 
There were 28 anastomotic stenoses in 27 vein grafts. 
These responded well to PTA, with 24 grafts (86%) 
being patent at follow-up. The three occlusions which 
occurred were two veins of generally poor calibre and 
the one w i th four  stenoses. 
PTFE grafts. There were 10 stenoses in eight PTFE 
grafts - three in the graft body and seven in the 
anastomotic regions. 
Three grafts occluded - at the time of PTA, at 10 
days post-PTA and 12 months later. All three had graft 
body stenoses. One of these graft body stenoses was 
Fig. 1. Long stenosis in a below knee femoropopliteal reversed 
vein graft. Following PTA rapid restenosis occurred and a jump 
graft was performed. 
not dilated but was associated with PTA of an an- 
astomotic stenosis. 
Three grafts with anastomotic stenoses remained 
patent 4, 13 and 21 months later. 
One limb was amputated 12 months later for venous 
ulceration after dilatation of an anastomotic stenosis. 
The graft was patent at the time of amputation. 
One was lost to follow-up. 
Grafts with multiple stenoses n = 8 (G). Three grafts had 
occluded: two poor quality veins with multiple 
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Fig. 2. Short web stenosis - successful PTA was performed. 
stenoses and a PTFE graft with two stenoses. Five 
grafts, each with two stenoses, remained patent at 
median follow-up of 11 months. In one of these a jump 
graft had been performed. 
Surgical intervention 
Adjunctive surgery to maintain patency was required 
in six cases: three jump grafts and one vein patch 
angioptasty were performed for long stenoses with 
technically poor results at PTA. Two further jump 
grafts were performed for native vessel disease ad- 
jacent o the anastomosis, one the proximal and one 
the distal anastomosis. 
Discussion 
The results of this study are comparable with others 3
and both vein and some PTFE graft stenoses appear 
to benefit from PTA with an overall good outcome. 
Fig. 3. Short tubular stenosis. 
Only one stenosis was inaccessible in this series, and 
the only significant complication was one PTFE graft 
occlusion occurring at the time of PTA of a mid-graft 
stenosis. 
One has to question whether the graft angioplasties 
were all necessary, and whether the stenoses which 
were treated would have progressed to cause graft 
occlusion in all or most cases. The only way to answer 
this would be a controlled clinical trial, randomising 
grafts with stenoses to either PTA or observation only. 
In view of the known natural history of graft stenoses, 
which are associated with a three-fold increased risk 
of graft occlusion, 1°the results of retrospective om-
parisons uggesting very much higher secondary pat- 
ency rates in stenotic grafts in which intervention has 
been performed, 1~and the authors' previous ex- 
perience when stenoses which were treated too late 
were associated with graft occlusion, 12this would ap- 
pear unethical. 
It is clear that some graft-related stenoses are not 
suitable for PTA. These are: grafts with three or more 
stenoses; tenoses longer than 2 cm; mid-graft stenoses 
in PTFE grafts. 
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Fig. 4. Successful PTA of the stenosis shown in Fig. 3. 
The presence of three or more stenoses in a graft is 
most likely an indicator of poor quality vein, and 
surgical revision is usually more appropriate than 
PTA. Long stenoses >2 cm in length did badly with 
PTA in this series, and this is in agreement with the 
results of other groups. ~°'~1 Surgery is indicated for 
these stenoses. 
The aetiology of mid-graft stenoses in PTFE grafts 
is unclear. There were five in this series, and all were 
situated in close proximity to the knee joint. This 
suggests that repeated flexing of the knee may damage 
the graft pseudointima, with resulting local thrombus 
formation. The right treatment of these stenoses i also 
unclear. One of the stenoses was left alone and was 
associated with graft occlusion 10 days later. The other 
four stenoSes (three grafts) occluded at the time of and 
at 2 and 12 months following PTA. It would appear 
likely that these lesions are a precursor of PTFE graft 
occlusion and some form of treatment would therefore 
appear indicated. Local thrombolysis has recently been 
suggested, 13 but for this to be effective an adequate 
concentration has to be maintained locally for a suf- 
ficient time, and this is difficult with a patent graft. 
By contrast, a recent similar PTFE graft stenosis in our 
Fig. 5. Anastomotic stenosis at the lower end of a PTFE graft. 
experience disappeared spontaneously, which sug- 
gests that dissolution of local thrombus may occur in 
some cases. 
There remains controversy over whether the prim- 
ary treatment of vein graft stenoses hould be PTA or 
surgery. The proponents of surgery point tothe higher 
recurrence and failure rates of stenoses treated by 
PTA, with combined rates of 33-50% being reported. 9 
Although these figures would appear too high, it is 
likely that there is indeed a higher recurrence rate of 
stenosis following PTA when compared to surgery. 
However, PTA is easily repeatable and well tolerated 
by the patient when repeated on several occasaons. In 
the study by London et al. a single PTA was effective 
in 70% and two PTAs in 85% stenoses. 3 In our study, 
if the long stenoses, grafts with three or more stenoses 
Eur J Vasc Endovasc Surg Vol 14, November 1997 
Percutaneous Angioplasty and Graft-related Stenoses 385 
With four exceptions, all the vein graft stenoses 
occurring more than 1 year following surgery were 
anastomotic in nature. These late stenoses presented 
as a result of symptoms and were not detected by 
a graft surveillance programme. Because of this, no 
conclusions regarding the duration of a graft sur- 
veillance programme can be drawn. These data would 
suggest, however, that some grafts will be threatened 
by anastomotic stenoses indefinitely following surgery 
and may benefit from PTA. Further studies are needed 
to investigate this. 
We conclude that PTA should be the first line treat- 
ment for graft-related stenoses in vein grafts and for 
anastomotic stenoses in PTFE grafts. Close surveillance 
of all grafts following the initial PTA is important, as 
20% will require further intervention. Intervention 
while the graft is still patent, though haemo- 
dynamically compromised, will maximise the primary 
assisted and secondary graft patency rates. 
Fig. 6. The lower anastomosis of the graft shown in Fig. 5 3 months 
after PTA. 
and PTFE graft body stenoses are excluded from ana- 
lysis, a single PTA would have been effective in 76% 
(31/41 stenoses), with further PTAs increasing this 
patency to 90% (37/41 stenoses). Only two graft oc- 
clusions occurred in this group; one vein which was 
reported to be of poor calibre, and one PTFE graft; 
and only two surgical interventions were required in 
these grafts. This data would suggest that PTAs should 
be the initial treatment of short graft and anastomotic 
stenoses, with surgery being used as the primary 
treatment of long and multiple stenoses. 
There is a need for close surveillance of grafts fol- 
lowing PTA of graft-related stenoses, especially if a 
poor technical result has been achieved. Fourteen fur- 
ther procedures (six surgical, eight further PTA) were 
indicated following PTA and all were associated with 
patent grafts at follow-up a median of 21 months later. 
Most centres with a graft surveillance policy ad- 
vocate regular surveillance of vein but not PTFE grafts. 
The results of PTA for anastomotic stenoses in PTFE 
grafts would suggest hat the anastomotic regions of 
these grafts should be surveyed so that intervention 
can be planned prior to thrombosis occurring. The 
numbers are, however, too small to draw any firm 
conclusions. 
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